Charles River Laboratories | CRL - Capital Ordinaire

Prix De L'Action
169.80
Variation Quotidienne
2.06 1.23%
Mensuellement
2.36%
Annuel
48.09%
Q2 Prévisions
166.17




Capital Ordinaire Changement Date
Agilent USD 282.7M 358K 2025-12
Align Technology USD 71.75M 736K 2025-12
Bio-Rad Laboratories USD 26.97M 90K 2025-09
Bruker USD 151.94M 225K 2025-12
Cardinal Health USD 238M 1000K 2025-09
Charles River Laboratories USD 49.22M 2K 2025-12
Cigna USD 263.46M 3.14M 2025-12
Concord Medical Services Hldg CNY 130.25M 130.15M 2025-06
CVS Health USD 1.27B 1000K 2025-12
Danaher USD 707.7M 800K 2026-03
Dentsply International USD 199.5M 196.5M 2025-09
Elevance Health USD 217.37M 4.87M 2026-03
Galapagos EUR 65.9M 0 2025-12
Humana USD 120.59M 318K 2025-12
Illumina USD 152.8M 900K 2025-12
Incyte USD 198.46M 2.33M 2025-12
Intrexon USD 0 0 2024-06
IQVIA Holdings USD 169.6M 700K 2025-12
Laboratory Of America USD 82.2M 700K 2025-12
Lonza CHF 68.64M 0 2025-12
McKesson USD 280M 156M 2025-12
Merck EUR 434.78M 0 2025-12
Mettler Toledo International USD 20.43M 170.6K 2025-12
Novartis USD 1.91B 10.64M 2025-12
Pfizer USD 5.69B 1000K 2025-09
Quest Diagnostics USD 111M 1000K 2026-03
Revvity USD 113.38M 2.7M 2025-12
Thermo Fisher Scientific USD 371.62M 4.09M 2026-03
United Therapeutics USD 43.64M 740K 2025-12
UnitedHealth USD 907.68M 1.84M 2026-03
Veradigm USD 106.07M 103.28M 2022-12
Waters USD 98.08M 38.55M 2025-12
West Pharmaceutical Services USD 70.9M 1.1M 2026-03